Diabetic Retinopathy Screening and Monitoring of Early Stage Disease in Australian General Practice: Tackling Preventable Blindness within a Chronic Care Model

Journal of Diabetes Research
Lisa J CrosslandClaire L Jackson

Abstract

Diabetic retinopathy (DR) is the leading cause of preventable blindness in Australia. Up to 50% of people with proliferative DR who do not receive timely treatment will become legally blind within five years. Innovative and accessible screening, involving a variety of primary care providers, will become increasingly important if patients with diabetes are to receive optimal eye care. An open controlled trial design was used. Five intervention practices in urban, regional, and rural Australia partnered with ophthalmologists via telehealth undertook DR screening and monitoring of type 2 diabetes patients and were compared with control practices undertaking usual care 2011-2014. Recorded screening rates were 100% across intervention practices, compared with 22-53% in control practices. 31/577 (5%) of patients in the control practices were diagnosed with mild-moderate DR, of whom 9 (29%) had appropriate follow-up recorded. This was compared with 39/447 (9%) of patients in the intervention group, of whom 37 (95%) had appropriate follow-up recorded. General practice-based DR screening via Annual Cycle of Care arrangements is effective across differing practice locations. It offers improved recording of screening outcomes for Australi...Continue Reading

References

Oct 1, 2003·Clinical & Experimental Ophthalmology·Daniel J McCartyCatherine A McCarty
Feb 28, 2006·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Andreas MüllerJill Elizabeth Keeffe
Aug 23, 2007·JAMA : the Journal of the American Medical Association·Quresh MohamedTien Y Wong
Nov 22, 2007·Expert Opinion on Therapeutic Targets·Raymond M SchiffelersGert Storm
Nov 10, 2009·Diabetes Research and Clinical Practice·J E ShawP Z Zimmet
Feb 27, 2010·Deutsches Ärzteblatt International·Aris N Kollias, Michael W Ulbig
Jul 21, 2010·Australian and New Zealand Journal of Public Health·Geoffrey K P SpurlingClaire L Jackson
Apr 5, 2011·Current Opinion in Ophthalmology·Ribhi HazinMichael Summerfield
May 12, 2012·Contemporary Clinical Trials·Deborah A AskewClaire L Jackson
Jul 23, 2014·The Medical Journal of Australia·Tina JanamianCaroline Nicholson

❮ Previous
Next ❯

Citations

Jul 23, 2016·Journal of Telemedicine and Telecare·Irene J TanAngus W Turner
Mar 31, 2020·Acta Diabetologica·Paolo LanzettaUNKNOWN Vision Academy
Jan 10, 2017·Frontiers in Public Health·Anthea M BurnettRoss Bailie
Jan 18, 2020·Journal of Optometry·Dimitrios KalogeropoulosMarios Neofytou

❮ Previous
Next ❯

Software Mentioned

Empanelment
Stata

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.

© 2022 Meta ULC. All rights reserved